Offer - Urjas Oil for just ₹ 1 X
Nebicard LN 2.5 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Nebicard LN 2.5 Tablet (10) safe for pregnant women?
Nebicard LN Tablet shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebicard LN 2.5 Tablet (10) safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nebicard LN Tablet. It should only be taken after medical advice.
What is the effect of Nebicard LN 2.5 Tablet (10) on the Kidneys?
Nebicard LN Tablet rarely affects the kidneys.
What is the effect of Nebicard LN 2.5 Tablet (10) on the Liver?
Nebicard LN Tablet has very mild side effects on the liver.
What is the effect of Nebicard LN 2.5 Tablet (10) on the Heart?
Side effects of Nebicard LN Tablet rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Nebicard LN 2.5 Tablet (10) unless your doctor advises you to do so -
Is this Nebicard LN 2.5 Tablet (10) habit forming or addictive?
Nebicard LN 2.5 Tablet (10) is not addictive in nature.
Interaction between Food and Nebicard LN 2.5 Tablet (10)
Some foods when eaten with Nebicard LN 2.5 Tablet (10) can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Nebicard LN 2.5 Tablet (10)
Consumption of alcohol and Nebicard LN 2.5 Tablet (10) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897